It has been well acknowledged that AKT signaling promotes tumor cell proliferation, growth, and metastasis by activating its downstream effectors, and thus the inhibitors targeting this signaling pathway have been considered as the most effective treatment strategy for cancer [39]. This evidence concerns the gene AKT1 and cancer.